GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE

Clinical trials for GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE explained in plain language.

Never miss a new study

Get alerted when new GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE trials appear

Sign up with your email to follow new studies for GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for protecting kidneys in serious autoimmune attack

Disease control Recruiting now

This study is testing a new drug called ALE.F02 to see if it can help protect and preserve kidney function in people with a serious autoimmune disease called ANCA-associated vasculitis (AAV), which attacks the body's small blood vessels, especially in the kidneys. Researchers wil…

Matched conditions: GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE

Phase: PHASE2 • Sponsor: Alentis Therapeutics AG • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE

Get alerted when new GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE trials appear

New hope for protecting kidneys in serious autoimmune attack